Counterfeit drugs are a growing problem, but one company wants to use blockchain technology, which underpins bitcoin, to help eradicate it by creating an open and trusted record of where drugs have come from. According to CoinDesk [1], management consulting services company Accenture proposed the initiative at a meeting of the HyperLedger Project, which is run by the Linux Foundation and seeks to build an open-source repository of blockchain code that will address current gaps in the technology. “If we could get that data and prove that documents have not been tampered with, we could say the drug actually came from the factory that we say it came from,” Primrose Mbanefo, who heads up Accenture’s connected devices software, said at the meeting.
